Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 6 sources · 4 days · First seen · Last updated
US FDA menopausal hormone therapy labeling changes
Overview
The US Food and Drug Administration (FDA) has updated the labeling for several menopausal hormone therapy (MHT) products by removing boxed warnings. These warnings previously cited risks of cardiovascular disease, breast cancer, and probable dementia.
Following an initial action in February 2026 involving six products, the FDA approved updated labeling for three additional estradiol transdermal patches, specifically Minivelle, Vivelle, and Vivelle-Dot. The agency stated that this decision follows a re-evaluation of scientific data, noting that previous warnings were based on the Women’s Health Initiative study from the early 2000s, which focused on older demographics.
The agency indicated these actions support the executive order “Advancing Women’s Health to Improve Outcomes in All Phases of Life.” While there have been challenges regarding the availability of hormone replacement therapy patches due to rising demand, the FDA stated it is not aware of an imminent risk of a nationwide shortage.
Entities
Food and Drug Administration · U.S. Department of Health and Human Services · Evernow · US Department of Health and Human Services · Robert F. Kennedy Jr.
Timeline
-
[HEALTH] 5 sourcesUS Department of Health and Human Services adjusts medical regulations
The US HHS has removed Black Box warnings from certain menopause hormone patches and suspended enforcement against pharmacies selling unapproved peptides like BPC-157 to improve patient safety.
-
[HEALTH] 2 sourcesFDA removes boxed warnings from three menopausal hormone therapy products
The FDA has removed boxed warnings for cardiovascular disease, breast cancer, and dementia from three additional menopausal hormone therapy products, specifically estradiol transdermal patches.
Sources
contemporaryobgyn.net · herforward.com · iredellfreenews.com · radiologykey.com · tkp.at · upday.com